LIM, Hyungsuk,LYU, Chun Seon,PARK, Sun Young,SHIN, Kyungmin,OH, Da Won
申请号：
EP17888189
公开号：
EP3560482A4
申请日:
2017.12.26
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to a novel formulation comprising a benzimidazole derivative. The formulation for oral administration comprising a compound of Formula 1 according to the present invention or a pharmaceutically acceptable salt thereof； and at least one disintegrant selected from the group consisting of croscarmellose sodium, sodium starch glycolate and low-substituted hydroxypropylcellulose, exhibits an excellent storage stability and has an effect on preventing a phenomenon of decline in dissolution rate, thus being usefully used as a formulation for oral administration.
